Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation

Shock

Volumn 43, Issue 5, 2015, Pages 443-449

  Matsumoto, Hisatake ^a   Yamakawa, Kazuma ^a   Ogura, Hiroshi ^a   Koh, Taichin ^b   Matsumoto, Naoya ^a   Shimazu, Takeshi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

CD146 antigen; endothelial cell protein C receptor; flow cytometry; thrombomodulin; tissue factor

Indexed keywords

BIOLOGICAL MARKER; D DIMER; ENDOTHELIAL PROTEIN C RECEPTOR; FIBRINOGEN DEGRADATION PRODUCT; INTERLEUKIN 6; THROMBOMODULIN; THROMBOPLASTIN; CELL SURFACE RECEPTOR; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; FIBRINOGEN; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN; PROCR PROTEIN, HUMAN; THBD PROTEIN, HUMAN;

ADULT; AGED; ALGORITHM; ANTICOAGULATION; APACHE; ARTICLE; ASSESSMENT OF HUMANS; BLOOD SAMPLING; CELL SPECIFICITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM INJURY; FEMALE; FLOW CYTOMETRY; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL SOCIETY OF THROMBOSIS AND HAEMOSTASIS; MALE; PATIENT ASSESSMENT; SCORING SYSTEM; SEPSIS; SEPSIS INDUCED DISSEMINATED INTRAVASCULAR COAGULATION; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; THROMBOCYTE POOR PLASMA; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; ENDOTHELIUM; GENE EXPRESSION REGULATION; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SURFACE PROPERTY; TIME FACTOR;

ADULT; AGED; ALGORITHMS; ANTIGENS, CD; ANTIGENS, SURFACE; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DISSEMINATED INTRAVASCULAR COAGULATION; ENDOTHELIUM; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; SEPSIS; SURFACE PROPERTIES; THROMBOMODULIN; THROMBOPLASTIN; TIME FACTORS;

EID: 84928604065     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000331     Document Type: Article

References (35)

1. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al.: Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39(2):165-228, 2013.
2. Levi M, van der Poll T: Endothelial injury in sepsis. Intensive Care Med 39(10):1839-1842, 2013.
3. Letsky EA: Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol 15(4):623-644, 2001.
4. Gando S, Kameue T, Nanzaki S, Nakanishi Y: Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 75(2):224-228, 1996.
5. Ishikura H, Nishida T, Murai A, Nakamura Y, Irie Y, Tanaka J, Umemura T: New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study. Crit Care 18(1):R19, 2014.
6. Zeerleder S, Hack CE, Wuillemin WA: Disseminated intravascular coagulation in sepsis. Chest 128(4):2864-2875, 2005.
7. Meziani F, Delabranche X, Asfar P, Toti F: Bench-to-bedside review: circulating microparticlesVa new player in sepsis Crit Care 14(5):236, 2010.
8. Reid VL, Webster NR: Role of microparticles in sepsis. Br J Anaesth 109(4):503-513, 2012.
9. Aras O, Shet A, Bach RR, Hysjulien JL, Slungaard A, Hebbel RP, Escolar G, Jilma B, Key NS: Induction of microparticle-and cell-associated intravascular tissue factor in human endotoxemia. Blood 103(12):4545-4553, 2004.
10. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F, Mutin M, Sanmarco M, Sampol J, Dignat-George F: In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 104(1):93-102, 1999.
11. Pérez-Casal M, Thompson V, Downey C, Welters I, Wyncoll D, Thachil J, Toh CH: The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis. Crit Care 15(4):R195, 2011.
12. Woei-A-Jin FJ, De Kruif MD, Garcia Rodriguez P, Osanto S, Bertina RM: Microparticles expressing tissue factor are concurrently released with markers of inflammation and coagulation during human endotoxemia. J Thromb Haemost 10(6):1185-1188, 2012.
13. Key NS: Analysis of tissue factor positive microparticles. Thromb Res 125(Suppl 1):S42-S45, 2010.
14. Satta N, Freyssinet JM, Toti F: The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. Br J Haematol 96(3):534-542, 1997.
15. Pérez-Casal M, Downey C, Cutillas-Moreno B, Zuzel M, Fukudome K, Toh CH: Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects. Haematologica 94(3): 387-394, 2009.
16. Ogura H, Tanaka H, Koh T, Fujita K, Fujimi S, Nakamori Y, Hosotsubo H, Kuwagata Y, Shimazu T, Sugimoto H: Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome. J Trauma 56(4):823-830, 2004.
17. Delabranche X, Boisramé-Helms J, Asfar P, Berger A, Mootien Y, Lavigne T, Grunebaum L, Lanza F, Gachet C, Freyssinet JM, et al.: Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy. Intensive Care Med 39(10):1695-1703, 2013.
18. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4):1250-1256, 2003.
19. Bulut D, Maier K, Bulut-Streich N, Börgel J, Hanefeld C, Mügge A: Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J Card Fail 14(4):336-340, 2008.
20. Gordon C, Gudi K, Krause A, Sackrowitz R, Harvey BG, Strulovici-Barel Y, Mezey JG, Crystal RG: Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med 184(2):224-232, 2011.
21. Puddu P, Puddu GM, Cravero E, Muscari S, Muscari A: The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol 26(4):140-145, 2010.
22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 13(10):818-829, 1985.
23. Janssens U, Dujardin R, Graf J, Lepper W, Ortlepp J, Merx M, Zarse M, Reffelmann T, Hanrath P: Value of SOFA (Sequential Organ Failure Assessment) score and total maximum SOFA score in 812 patients with acute cardiovascular disorders. Crit Care 5(Suppl 1):P225, 2001.
24. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M: Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH): Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86(5):1327-1330, 2001.
25. Takemitsu T, Wada H, Hatada T, Ohmori Y, Ishikura K, Takeda T, Sugiyama T, Yamada N, Maruyama K, Katayama N, et al.: Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thromb Haemost 105(1):40-44, 2011.
26. Gando S, Saitoh D, Ogura H, Mayumi T, Koseki K, Ikeda T, Ishikura H, Iba T, Ueyama M, Eguchi Y, et al.: Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group: Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis. Thromb Res 123(5):715-718, 2009.
27. Steffel J, Luscher TF, Tanner FC: Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113(5):722-731, 2006.
28. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A: Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95(3):930-935, 2000.
29. Levi M, Van Der Poll T: Thrombomodulin in sepsis. Minerva Anestesiol 79(3):294-298, 2013.
30. Maruyama I, Majerus PW: The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin. J Biol Chem 260(29):15432-15438, 1985.
31. Ohlin AK, Larsson K, Hansson M: Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma. J Thromb Haemost 3(5):976-982, 2005.
32. Kerschen EJ, Fernandez JA, Cooley BC, Yang XV, Sood R, Mosnier LO, Castellino FJ, Mackman N, Griffin JH, Weiler H: Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J ExpMed 204(10):2439-2448, 2007.
33. Uitte de Willige S, Van Marion V, Rosendaal FR, Vos HL, de Visser MC, Bertina RM: Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost 2(8):1305-1310, 2004.
34. Hack CE, Zeerleder S: The endothelium in sepsis: source of and a target for inflammation. Crit Care Med 29(7 Suppl):S21-S27, 2001.
35. Amabile N, Guérin AP, Tedgui A, Boulanger CM, London GM: Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol Dial Transplant 27(5):1873-1880, 2012.